AdaptHealth Signs Definitive Sale Agreement with Cardinal Health
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
SAN DIEGO, June 1, 2026 Resmed has completed its acquisition of Noctrix Health, significantly expanding its clinical sleep health...
